_id
6919edd53c536f8df231848f
Ticker
SBTX.LSE
Name
SkinBioTherapeutics PLC
Exchange
LSE
Address
The Core, Newcastle upon Tyne, United Kingdom, NE4 5TF
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.skinbiotherapeutics.com
Description
SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome to promote wound healing and reduce the risk of infection; AxisBiotix-Ps, which alleviate the symptoms associate with psoriasis; and MediBiotix, CleanBiotix, and PharmaBiotix which are in early stages of development. The company has an agreement with Croda Plc for the development of SkinBiotix as an active ingredient for the skicare and cosmetic industry. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
Last Close
152500
Volume
502213
Current Price
19.375
Change
3.9344262295081944
Last Updated
2025-12-30T11:29:56.775Z
Image
https://logo.clearbit.com/www.skinbiotherapeutics.com
Ipo Date
-
Market Cap
39463868
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
3061616
Cost Of Revenue
1233643
Gross Profit
1827973
Operating Expenses
1959599
Operating Income
-87586
Interest Expense
86229
Pretax Income
326185
Net Income
337847
Eps
0.001305540231374543
Dividends Per Share
-
Shares Outstanding
258779463
Income Tax Expense
-11662
EBITDA
657805
Operating Margin
-2.8607767923867655
Total Other Income Expense Net
413771
Cash
4779433
Short Term Investments
-
Receivables
1411261
Inventories
800154
Total Current Assets
7108215
Property Plant Equipment
728348
Total Assets
12125688
Payables
513328
Short Term Debt
224224
Long Term Debt
600000
Total Liabilities
2706591
Equity
9419097
Bs_currency_symbol
GBP
Depreciation
245391
Change In Working Capital
-651725
Cash From Operations
-494837
Capital Expenditures
3663
Cash From Investing
-120913
Cash From Financing
4158206
Net Change In Cash
3542456
Cf_currency_symbol
-
PE
-
PB
532.3070879963334
ROE
3.58683003264538
ROA
2.786208914496233
FCF
-498500
Fcf Percent
-0.16282250941986193
Piotroski FScore
2
Health Score
47
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
4
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
3061616
Quarters > 0 > income Statement > cost Of Revenue
1233643
Quarters > 0 > income Statement > gross Profit
1827973
Quarters > 0 > income Statement > operating Expenses
1959599
Quarters > 0 > income Statement > operating Income
-87586
Quarters > 0 > income Statement > interest Expense
86229
Quarters > 0 > income Statement > pretax Income
326185
Quarters > 0 > income Statement > net Income
337847
Quarters > 0 > income Statement > eps
0.001305540231374543
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
258779463
Quarters > 0 > income Statement > income Tax Expense
-11662
Quarters > 0 > income Statement > EBITDA
657805
Quarters > 0 > income Statement > operating Margin
-2.8607767923867655
Quarters > 0 > income Statement > total Other Income Expense Net
413771
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
4779433
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1411261
Quarters > 0 > balance Sheet > inventories
800154
Quarters > 0 > balance Sheet > total Current Assets
7108215
Quarters > 0 > balance Sheet > property Plant Equipment
728348
Quarters > 0 > balance Sheet > total Assets
12125688
Quarters > 0 > balance Sheet > payables
513328
Quarters > 0 > balance Sheet > short Term Debt
224224
Quarters > 0 > balance Sheet > long Term Debt
600000
Quarters > 0 > balance Sheet > total Liabilities
2706591
Quarters > 0 > balance Sheet > equity
9419097
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
337847
Quarters > 0 > cash Flow > depreciation
245391
Quarters > 0 > cash Flow > change In Working Capital
-651725
Quarters > 0 > cash Flow > cash From Operations
-494837
Quarters > 0 > cash Flow > capital Expenditures
3663
Quarters > 0 > cash Flow > cash From Investing
-120913
Quarters > 0 > cash Flow > cash From Financing
4158206
Quarters > 0 > cash Flow > net Change In Cash
3542456
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.001305540231374543
Quarters > 0 > ratios > PB
532.3070879963334
Quarters > 0 > ratios > ROE
3.58683003264538
Quarters > 0 > ratios > ROA
2.786208914496233
Quarters > 0 > ratios > FCF
-498500
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.16282250941986193
Quarters > 0 > health Score
47
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1577000
Quarters > 1 > income Statement > cost Of Revenue
698967
Quarters > 1 > income Statement > gross Profit
877564
Quarters > 1 > income Statement > operating Expenses
1913000
Quarters > 1 > income Statement > operating Income
-1036000
Quarters > 1 > income Statement > interest Expense
5752
Quarters > 1 > income Statement > pretax Income
-1041000
Quarters > 1 > income Statement > net Income
-1034000
Quarters > 1 > income Statement > eps
-0.004636521801517407
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
223012000
Quarters > 1 > income Statement > income Tax Expense
-7201
Quarters > 1 > income Statement > EBITDA
-881000
Quarters > 1 > income Statement > operating Margin
-65.69435637285986
Quarters > 1 > income Statement > total Other Income Expense Net
-5752
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1236977
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
501820
Quarters > 1 > balance Sheet > inventories
828033
Quarters > 1 > balance Sheet > total Current Assets
2566831
Quarters > 1 > balance Sheet > property Plant Equipment
478122
Quarters > 1 > balance Sheet > total Assets
7296500
Quarters > 1 > balance Sheet > payables
723340
Quarters > 1 > balance Sheet > short Term Debt
100254
Quarters > 1 > balance Sheet > long Term Debt
956543
Quarters > 1 > balance Sheet > total Liabilities
2808765
Quarters > 1 > balance Sheet > equity
4487735
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-1034100
Quarters > 1 > cash Flow > depreciation
154356
Quarters > 1 > cash Flow > change In Working Capital
85970
Quarters > 1 > cash Flow > cash From Operations
-803216
Quarters > 1 > cash Flow > capital Expenditures
2634
Quarters > 1 > cash Flow > cash From Investing
-1500447
Quarters > 1 > cash Flow > cash From Financing
2739736
Quarters > 1 > cash Flow > net Change In Cash
436073
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.004636521801517407
Quarters > 1 > ratios > PB
962.8147606754854
Quarters > 1 > ratios > ROE
-23.040576148101437
Quarters > 1 > ratios > ROA
-14.171177962036593
Quarters > 1 > ratios > FCF
-805850
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.511001902346227
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1102000
Quarters > 2 > income Statement > cost Of Revenue
527809
Quarters > 2 > income Statement > gross Profit
574284
Quarters > 2 > income Statement > operating Expenses
2093000
Quarters > 2 > income Statement > operating Income
-1519000
Quarters > 2 > income Statement > interest Expense
39924
Quarters > 2 > income Statement > pretax Income
-1559000
Quarters > 2 > income Statement > net Income
-1541000
Quarters > 2 > income Statement > eps
-0.007891273511232647
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
195279000
Quarters > 2 > income Statement > income Tax Expense
-17659
Quarters > 2 > income Statement > EBITDA
-1396000
Quarters > 2 > income Statement > operating Margin
-137.84029038112521
Quarters > 2 > income Statement > total Other Income Expense Net
-39924
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
800904
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
341154
Quarters > 2 > balance Sheet > inventories
472419
Quarters > 2 > balance Sheet > total Current Assets
1671411
Quarters > 2 > balance Sheet > property Plant Equipment
116369
Quarters > 2 > balance Sheet > total Assets
5215064
Quarters > 2 > balance Sheet > payables
281062
Quarters > 2 > balance Sheet > short Term Debt
778881
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
2245183
Quarters > 2 > balance Sheet > equity
2969881
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-1541179
Quarters > 2 > cash Flow > depreciation
123216
Quarters > 2 > cash Flow > change In Working Capital
-152227
Quarters > 2 > cash Flow > cash From Operations
-1397663
Quarters > 2 > cash Flow > capital Expenditures
13217
Quarters > 2 > cash Flow > cash From Investing
-2220108
Quarters > 2 > cash Flow > cash From Financing
1578153
Quarters > 2 > cash Flow > net Change In Cash
-2039618
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.007891273511232647
Quarters > 2 > ratios > PB
1273.9670798257573
Quarters > 2 > ratios > ROE
-51.887600883671766
Quarters > 2 > ratios > ROA
-29.54901416358457
Quarters > 2 > ratios > FCF
-1410880
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.2802903811252269
Quarters > 2 > health Score
23
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
106576
Quarters > 3 > income Statement > cost Of Revenue
38353
Quarters > 3 > income Statement > gross Profit
68223
Quarters > 3 > income Statement > operating Expenses
1454000
Quarters > 3 > income Statement > operating Income
-1386000
Quarters > 3 > income Statement > interest Expense
11477
Quarters > 3 > income Statement > pretax Income
-1390000
Quarters > 3 > income Statement > net Income
-1335000
Quarters > 3 > income Statement > eps
-0.007547361815437323
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
176883000
Quarters > 3 > income Statement > income Tax Expense
-55243
Quarters > 3 > income Statement > EBITDA
-1362000
Quarters > 3 > income Statement > operating Margin
-1300.4804083470951
Quarters > 3 > income Statement > total Other Income Expense Net
-3836
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2840522
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
164557
Quarters > 3 > balance Sheet > inventories
46947
Quarters > 3 > balance Sheet > total Current Assets
3289815
Quarters > 3 > balance Sheet > property Plant Equipment
160409
Quarters > 3 > balance Sheet > total Assets
4211397
Quarters > 3 > balance Sheet > payables
463287
Quarters > 3 > balance Sheet > short Term Debt
74722
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
560337
Quarters > 3 > balance Sheet > equity
3651060
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-1334811
Quarters > 3 > cash Flow > depreciation
45116
Quarters > 3 > cash Flow > change In Working Capital
14864
Quarters > 3 > cash Flow > cash From Operations
-1365469
Quarters > 3 > cash Flow > capital Expenditures
14959
Quarters > 3 > cash Flow > cash From Investing
-76484
Quarters > 3 > cash Flow > cash From Financing
2970641
Quarters > 3 > cash Flow > net Change In Cash
1528688
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.007547361815437323
Quarters > 3 > ratios > PB
938.6611353962959
Quarters > 3 > ratios > ROE
-36.56472366929056
Quarters > 3 > ratios > ROA
-31.699694899341
Quarters > 3 > ratios > FCF
-1380428
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-12.952522143822248
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
4638147
Annuals > 0 > income Statement > cost Of Revenue
1932610
Annuals > 0 > income Statement > gross Profit
2705537
Annuals > 0 > income Statement > operating Expenses
3532323
Annuals > 0 > income Statement > operating Income
-826786
Annuals > 0 > income Statement > interest Expense
91981
Annuals > 0 > income Statement > pretax Income
-715116
Annuals > 0 > income Statement > net Income
-696253
Annuals > 0 > income Statement > eps
-0.003055524971180654
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
227866899
Annuals > 0 > income Statement > income Tax Expense
-18863
Annuals > 0 > income Statement > EBITDA
-196540
Annuals > 0 > income Statement > operating Margin
-17.825782580845324
Annuals > 0 > income Statement > total Other Income Expense Net
111670
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
4779433
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1411261
Annuals > 0 > balance Sheet > inventories
800154
Annuals > 0 > balance Sheet > total Current Assets
7108215
Annuals > 0 > balance Sheet > property Plant Equipment
728348
Annuals > 0 > balance Sheet > total Assets
12125688
Annuals > 0 > balance Sheet > payables
513328
Annuals > 0 > balance Sheet > short Term Debt
112112
Annuals > 0 > balance Sheet > long Term Debt
600000
Annuals > 0 > balance Sheet > total Liabilities
2706591
Annuals > 0 > balance Sheet > equity
9419097
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-715116
Annuals > 0 > cash Flow > depreciation
426595
Annuals > 0 > cash Flow > change In Working Capital
-565755
Annuals > 0 > cash Flow > cash From Operations
-1298053
Annuals > 0 > cash Flow > capital Expenditures
6297
Annuals > 0 > cash Flow > cash From Investing
-1621360
Annuals > 0 > cash Flow > cash From Financing
6897942
Annuals > 0 > cash Flow > net Change In Cash
3978529
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.003055524971180654
Annuals > 0 > ratios > PB
381.9918549739959
Annuals > 0 > ratios > ROE
-7.391929396204329
Annuals > 0 > ratios > ROA
-5.741966971276186
Annuals > 0 > ratios > FCF
-1304350
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.2812222208567344
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
1209000
Annuals > 1 > income Statement > cost Of Revenue
525631
Annuals > 1 > income Statement > gross Profit
683038
Annuals > 1 > income Statement > operating Expenses
3588000
Annuals > 1 > income Statement > operating Income
-2905000
Annuals > 1 > income Statement > interest Expense
51401
Annuals > 1 > income Statement > pretax Income
-2949000
Annuals > 1 > income Statement > net Income
-2876000
Annuals > 1 > income Statement > eps
-0.015438543752382078
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
186287000
Annuals > 1 > income Statement > income Tax Expense
-72902
Annuals > 1 > income Statement > EBITDA
-2722000
Annuals > 1 > income Statement > operating Margin
-240.2812241521919
Annuals > 1 > income Statement > total Other Income Expense Net
-43760
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
800904
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
341154
Annuals > 1 > balance Sheet > inventories
472419
Annuals > 1 > balance Sheet > total Current Assets
1671411
Annuals > 1 > balance Sheet > property Plant Equipment
116369
Annuals > 1 > balance Sheet > total Assets
5215064
Annuals > 1 > balance Sheet > payables
281062
Annuals > 1 > balance Sheet > short Term Debt
778881
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
2245183
Annuals > 1 > balance Sheet > equity
2969881
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-2948892
Annuals > 1 > cash Flow > depreciation
175973
Annuals > 1 > cash Flow > change In Working Capital
-172758
Annuals > 1 > cash Flow > cash From Operations
-2726316
Annuals > 1 > cash Flow > capital Expenditures
198169
Annuals > 1 > cash Flow > cash From Investing
-2296592
Annuals > 1 > cash Flow > cash From Financing
4511978
Annuals > 1 > cash Flow > net Change In Cash
-510930
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.015438543752382078
Annuals > 1 > ratios > PB
990.4342059496659
Annuals > 1 > ratios > ROE
-96.83889691203116
Annuals > 1 > ratios > ROA
-55.14793298797483
Annuals > 1 > ratios > FCF
-2924485
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.4189288668320925
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
132057
Annuals > 2 > income Statement > cost Of Revenue
46867
Annuals > 2 > income Statement > gross Profit
85190
Annuals > 2 > income Statement > operating Expenses
3084542
Annuals > 2 > income Statement > operating Income
-2999352
Annuals > 2 > income Statement > interest Expense
8886
Annuals > 2 > income Statement > pretax Income
-3008238
Annuals > 2 > income Statement > net Income
-2835149
Annuals > 2 > income Statement > eps
-0.017212656107474668
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
164713045
Annuals > 2 > income Statement > income Tax Expense
-173089
Annuals > 2 > income Statement > EBITDA
-2955160
Annuals > 2 > income Statement > operating Margin
-2271.2555941752425
Annuals > 2 > income Statement > total Other Income Expense Net
-8886
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
1311834
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
816
Annuals > 2 > balance Sheet > inventories
33497
Annuals > 2 > balance Sheet > total Current Assets
1720761
Annuals > 2 > balance Sheet > property Plant Equipment
173160
Annuals > 2 > balance Sheet > total Assets
2594252
Annuals > 2 > balance Sheet > payables
194274
Annuals > 2 > balance Sheet > short Term Debt
62090
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
599342
Annuals > 2 > balance Sheet > equity
1994910
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-2835149
Annuals > 2 > cash Flow > depreciation
44193
Annuals > 2 > cash Flow > change In Working Capital
51293
Annuals > 2 > cash Flow > cash From Operations
-2645135
Annuals > 2 > cash Flow > capital Expenditures
165277
Annuals > 2 > cash Flow > cash From Investing
-165277
Annuals > 2 > cash Flow > cash From Financing
2317323
Annuals > 2 > cash Flow > net Change In Cash
-493089
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.017212656107474668
Annuals > 2 > ratios > PB
1303.7274767032095
Annuals > 2 > ratios > ROE
-142.11914321949362
Annuals > 2 > ratios > ROA
-109.28579798724256
Annuals > 2 > ratios > FCF
-2810412
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-21.281810127444967
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
74761
Annuals > 3 > income Statement > cost Of Revenue
29424
Annuals > 3 > income Statement > gross Profit
45337
Annuals > 3 > income Statement > operating Expenses
3027425
Annuals > 3 > income Statement > operating Income
-2982088
Annuals > 3 > income Statement > interest Expense
10135
Annuals > 3 > income Statement > pretax Income
-2992223
Annuals > 3 > income Statement > net Income
-2792601
Annuals > 3 > income Statement > eps
-0.017812200512314576
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
156780236
Annuals > 3 > income Statement > income Tax Expense
-199622
Annuals > 3 > income Statement > EBITDA
-2952419
Annuals > 3 > income Statement > operating Margin
-3988.828399834138
Annuals > 3 > income Statement > total Other Income Expense Net
-10135
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
1804923
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
12901
Annuals > 3 > balance Sheet > inventories
122571
Annuals > 3 > balance Sheet > total Current Assets
2332560
Annuals > 3 > balance Sheet > property Plant Equipment
126902
Annuals > 3 > balance Sheet > total Assets
3084967
Annuals > 3 > balance Sheet > payables
72610
Annuals > 3 > balance Sheet > short Term Debt
-4595
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
609606
Annuals > 3 > balance Sheet > equity
2475361
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-2792601
Annuals > 3 > cash Flow > depreciation
29672
Annuals > 3 > cash Flow > change In Working Capital
110147
Annuals > 3 > cash Flow > cash From Operations
-2673031
Annuals > 3 > cash Flow > capital Expenditures
96813
Annuals > 3 > cash Flow > cash From Investing
-96813
Annuals > 3 > cash Flow > cash From Financing
-35122
Annuals > 3 > cash Flow > net Change In Cash
-2804966
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.017812200512314576
Annuals > 3 > ratios > PB
1000.0803625976171
Annuals > 3 > ratios > ROE
-112.8159084674922
Annuals > 3 > ratios > ROA
-90.52288079580754
Annuals > 3 > ratios > FCF
-2769844
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-37.04931715734139
Annuals > 3 > health Score
26
Valuation > metrics > PE
0.001305540231374543
Valuation > metrics > PB
532.3070879963334
Valuation > final Score
40
Valuation > verdict
8771.8% Overvalued
Profitability > metrics > ROE
3.58683003264538
Profitability > metrics > ROA
4.75290913400903
Profitability > metrics > Net Margin
0.11034924040114763
Profitability > final Score
38
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.28735143082187176
Risk > metrics > Interest Coverage
-1.0157371649908964
Risk > final Score
56
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.637578096188472
Liquidity > metrics > Quick Ratio
8.55270001301603
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-672
Prev Risks > 1
-104
Prev Risks > 2
-423
Prev Liquidities > 0
100
Prev Liquidities > 1
89
Prev Liquidities > 2
100
Updated At
2026-01-20T23:03:54.256Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-24
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-12-02
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-03-26
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-28
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-0.01
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-09-30
Earnings History > 4 > report Date
2022-12-15
Earnings History > 4 > date
2022-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.01
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-03-29
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-09-30
Earnings History > 6 > report Date
2021-11-30
Earnings History > 6 > date
2021-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.01
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-12-31
Earnings History > 7 > report Date
2021-03-15
Earnings History > 7 > date
2020-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-09-30
Earnings History > 8 > report Date
2020-12-04
Earnings History > 8 > date
2020-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.01
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-03
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-0.01
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-09-30
Earnings History > 10 > report Date
2019-11-26
Earnings History > 10 > date
2019-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-12-31
Earnings History > 11 > report Date
2019-02-14
Earnings History > 11 > date
2018-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-09-30
Earnings History > 12 > report Date
2018-10-25
Earnings History > 12 > date
2018-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-02-21
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-10-05
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-12-31
Earnings History > 15 > report Date
2017-02-03
Earnings History > 15 > date
2016-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome to promote wound healing and reduce the risk of infection; AxisBiotix-Ps, which alleviate the symptoms associate with psoriasis; and MediBiotix, CleanBiotix, and PharmaBiotix which are in early stages of development. The company has an agreement with Croda Plc for the development of SkinBiotix as an active ingredient for the skicare and cosmetic industry. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AUK Life Sciences Visibility Expands as SkinBioTherapeutics Aligns with FTSE AIM All-Share Kalkine Media
Read more →SkinBioTherapeutics (LSE:SBTX) Tracks Sector Shifts Across the FTSE AIM All-Share Landscape Kalkine Media
Read more →Showing 2 of 3
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of SkinBioTherapeutics PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
—
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.